<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://pharmacopedia.wiki/index.php?action=history&amp;feed=atom&amp;title=Percodan</id>
	<title>Percodan - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://pharmacopedia.wiki/index.php?action=history&amp;feed=atom&amp;title=Percodan"/>
	<link rel="alternate" type="text/html" href="https://pharmacopedia.wiki/index.php?title=Percodan&amp;action=history"/>
	<updated>2026-05-28T09:23:56Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.46.0-beta</generator>
	<entry>
		<id>https://pharmacopedia.wiki/index.php?title=Percodan&amp;diff=6914&amp;oldid=prev</id>
		<title>MDElliottMD: home-claude category backfill (parser-claude gap closure)</title>
		<link rel="alternate" type="text/html" href="https://pharmacopedia.wiki/index.php?title=Percodan&amp;diff=6914&amp;oldid=prev"/>
		<updated>2026-05-23T10:43:45Z</updated>

		<summary type="html">&lt;p&gt;home-claude category backfill (parser-claude gap closure)&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw-interface=&quot;&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 10:43, 23 May 2026&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l21&quot;&gt;Line 21:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 21:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;== References ==&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;== References ==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;references /&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;references /&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;[[Category:Opioid analgesics]]&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;[[Category:NSAIDs]]&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;[[Category:Schedule II controlled substances]]&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;[[Category:Fixed-dose combinations]]&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>MDElliottMD</name></author>
	</entry>
	<entry>
		<id>https://pharmacopedia.wiki/index.php?title=Percodan&amp;diff=6512&amp;oldid=prev</id>
		<title>MDElliottMD: parser-claude batch MedTemplate pre-fill, mind-medicine combination</title>
		<link rel="alternate" type="text/html" href="https://pharmacopedia.wiki/index.php?title=Percodan&amp;diff=6512&amp;oldid=prev"/>
		<updated>2026-05-23T04:44:11Z</updated>

		<summary type="html">&lt;p&gt;parser-claude batch MedTemplate pre-fill, mind-medicine combination&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;{{MedTemplate&lt;br /&gt;
| generic           = Oxycodone / Aspirin&lt;br /&gt;
| brand             = Percodan&lt;br /&gt;
| structure         =&lt;br /&gt;
| classes           = [[:Category:Opioid_analgesics|Opioid analgesic]], [[:Category:NSAIDs|NSAID (aspirin)]], [[:Category:Schedule_II_controlled_substances|Schedule II controlled substance]], [[:Category:Fixed-dose_combinations|Fixed-dose combination]]&lt;br /&gt;
| uses              = &amp;lt;vote slug=&amp;quot;moderate-severe-acute-pain-use&amp;quot;&amp;gt;Moderate to moderately severe acute pain (less commonly prescribed than acetaminophen-opioid combinations due to NSAID GI risk)&amp;lt;/vote&amp;gt;&lt;br /&gt;
| starting_dose     = 1 tablet (4.8355 mg oxycodone / 325 mg aspirin) PO every 6 hours as needed&lt;br /&gt;
| preparations      = 4.8355 mg oxycodone / 325 mg aspirin tablets&lt;br /&gt;
| fda_max           = Aspirin GI/bleeding-limited; oxycodone titrated to effect&lt;br /&gt;
| pill_id           =&lt;br /&gt;
| routes            = Oral&lt;br /&gt;
| onset             = 15-30 minutes&lt;br /&gt;
| duration          = 4-6 hours&lt;br /&gt;
| halflife          = Oxycodone 3-5 hours; aspirin (acetyl group) 15-20 minutes, salicylate 2-3 hours at therapeutic doses&amp;lt;ref name=&amp;quot;percodan-label&amp;quot;&amp;gt;FDA Prescribing Information, Percodan (oxycodone / aspirin), Endo, current revision. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/012490s019lbl.pdf&amp;lt;/ref&amp;gt;&lt;br /&gt;
| bioavailability   = Oxycodone 60-87%; aspirin 50-75%&amp;lt;ref name=&amp;quot;percodan-label&amp;quot; /&amp;gt;&lt;br /&gt;
| pregnancy         = Avoid; aspirin teratogenicity concerns plus opioid neonatal withdrawal.{{citation needed}}&lt;br /&gt;
| legal             = [[USLegal:Schedule II|Schedule II controlled substance]] in US&lt;br /&gt;
| mechanism         = &amp;lt;vote slug=&amp;quot;percodan-mech-claim&amp;quot;&amp;gt;Oxycodone provides μ-opioid receptor agonism for opioid analgesia; aspirin (acetylsalicylic acid) provides non-selective COX-1/COX-2 inhibition with anti-inflammatory and antiplatelet effects in addition to analgesic.&amp;lt;/vote&amp;gt; Falling out of favor for acute pain due to aspirin&amp;#039;s GI bleeding and antiplatelet effects compared with acetaminophen-opioid combinations; still used in selected indications&amp;lt;ref name=&amp;quot;percodan-label&amp;quot; /&amp;gt;.&lt;br /&gt;
}}&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;/div&gt;</summary>
		<author><name>MDElliottMD</name></author>
	</entry>
</feed>